Teva UK Ltd v Janssen Pharmaceutica NA: PatC 16 Nov 2020

First case management conference in a claim for a declaration that a Supplementary Protection Certificate is invalid and should be revoked.

Citations:

[2020] EWHC 3157 (Pat)

Links:

Bailii

Jurisdiction:

England and Wales

Intellectual Property

Updated: 15 August 2022; Ref: scu.657796